Health canada usage of real world evidence (rwe) in regulatory decision making compared with fda/ema usage based on publicly available information

HIGHLIGHTS

• who: Catherine Y Lau et al. from the , have published the paper: Health Canada Usage of Real World Evidence (RWE) in Regulatory Decision Making compared with FDA/EMA usage based on publicly available information, in the Journal: (JOURNAL) of April/16,/2019
• what: Mention of the review of RWE - inconclusive whether it was used for decision making 5. The third limitation was the study only focused on oncology drugs and nononcology orphan_drugs rather than the entire list of drugs approved.
• future: It is expected with the regulation modernization and the introduction of more . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.